Shots: The data contains HAVEN 3 (N=152) study evaluating Hemlibra (emicizumab) prophylaxis vs no prophylaxis with patients aged ≥12 yrs HAVEN 3 results: (reduction in treated bleeds 96%/qw, 97%/q2w); (zero […]readmore
Tags : results
Shots: The data included results from the ongoing long-term extension (LTE) P-1b study of aducanumab for the treatment of Alzheimer Disease The results for each dose are same as interimanalyses […]readmore
Shots: ATTR-ACT is a P-III global study with three-arms 20mg or 80mg PO QD vs PBO, including patients with variant (ATTRm), wild-type (ATTRwt), or hereditary ATTR-ACT results (N=441): Reduced all-cause […]readmore
Shots: The controlled, randomized Ph IIa trial in 168 patients with 58 HD KW6356 group,55 LD KW-6356 group, or a 55 placebo in ratio 1:1:1, with drug administration for 12 […]readmore